FTC’s Drug Settlement a Win for the Lawyers

  (Bloomberg Review) – Is Thursday’s $1.2 billion antitrust settlement between the Federal Trade Commission and Teva Pharmaceutical Industries a victory for consumers? Or is it a sign of government enforcement run amok? The answer to that question, it turns out, goes back to a 2013 U.S. Read More